Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00059761

Public ClinicalTrials.gov record NCT00059761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 8:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Study of Irinotecan and Cisplatin in Combination With Twice Daily Thoracic Radiotherapy (45 Gy) or Once Daily Thoracic Radiotherapy (70 Gy) for Patients With Limited Stage Small Cell Lung Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase I trial to study the effect on the body when combining irinotecan and cisplatin with radiation therapy in treating patients who have limited-stage small cell lung cancer that could not be completely removed during surgery.

Study identification

NCT ID
NCT00059761
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
36 participants

Conditions and interventions

Conditions

Interventions

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2003
Primary completion
Feb 28, 2009
Completion
Oct 31, 2013
Last update posted
Nov 16, 2015

2003 – 2013

United States locations

U.S. sites
49
U.S. states
19
U.S. cities
42
Facility City State ZIP Site status
Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham Alabama 35294
Providence Saint Joseph Medical Center - Burbank Burbank California 91505
Saint Rose Hospital Hayward California 94545
Valley Memorial Hospital Livermore California 94550
Highland General Hospital at St. George's University School of Medicine Oakland California 94602
CCOP - Bay Area Tumor Institute Oakland California 94609
Summit Medical Center Oakland California 94609
J.C. Robinson, M.D. Regional Cancer Center San Pablo California 94806
CCOP - Christiana Care Health Services Newark Delaware 19718
Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale Florida 33308
University of Florida Shands Cancer Center Gainesville Florida 32610
Memorial Cancer Institute at Memorial Regional Hospital Hollywood Florida 33021
Ella Milbank Foshay Cancer Center at Jupiter Medical Center Jupiter Florida 33458
Baptist-South Miami Regional Cancer Program Miami Florida 33176
CCOP - Mount Sinai Medical Center Miami Beach Florida 33140
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Wendt Regional Cancer Center at Finley Hospital Dubuque Iowa 52001
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114
William Beaumont Hospital - Royal Oak Campus Royal Oak Michigan 48073
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203
Monmouth Medical Center Long Branch New Jersey 07740
Fox Chase Virtua Health Cancer Program - Marlton Mount Holly New Jersey 08060
AtlantiCare Regional Medical Center Pomona New Jersey 08240
Tucker Center for Cancer Care at Orange Regional Medical Center Middletown New York 10940
SUNY Upstate Medical University Hospital Syracuse New York 13210
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599
Duke Comprehensive Cancer Center Durham North Carolina 27710
Wayne Memorial Hospital, Incorporated Goldsboro North Carolina 27534
Wayne Radiation Oncology Goldsboro North Carolina 27534
Wilson Medical Center Wilson North Carolina 27893
McDowell Cancer Center at Akron General Medical Center Akron Ohio 44307
Delaware County Regional Cancer Center at Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107
Albert Einstein Cancer Center Philadelphia Pennsylvania 19141
Mercy Cancer Institute at Mercy Hospital Pittsburgh Pennsylvania 15219
Bon Secours St. Francis Health System Greenville South Carolina 29601
Greenville Hospital System Cancer Center Greenville South Carolina 29605
CCOP - Greenville Greenville South Carolina 29615
Sarah Cannon Cancer Center at Parkridge Medical Center Chattanooga Tennessee 37404
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232
M.D. Anderson Cancer Center at University of Texas Houston Texas 77030
Cottonwood Hospital Medical Center Murray Utah 84107
McKay-Dee Hospital Center Ogden Utah 84403
Utah Valley Regional Medical Center - Provo Provo Utah 84603
Utah Cancer Specialists at UCS Cancer Center Salt Lake City Utah 84106
LDS Hospital Salt Lake City Utah 84143
Dixie Regional Medical Center St. George Utah 84770
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00059761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2015 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00059761 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →